- Investing Ideas
- Chilean Pharmaceuticals & Biotech Potentially Undervalued Companies
Chilean Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
8
Companies with a Value score of at least 3, ordered by Value score
8 companies
Gilead Sciences
Market Cap: CL$177.9b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDCL
CL$127,000.00
7D
4.2%
1Y
60.8%
Gilead Sciences
Market Cap: US$177.9b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$138.92
7D
4.4%
1Y
25.8%
Amgen
Market Cap: CL$229.9b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGNCL
CL$383,390.00
7D
0.3%
1Y
30.7%
Eli Lilly
Market Cap: US$1.1t
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$1,183.20
7D
-4.0%
1Y
66.6%
Biogen
Market Cap: CL$31.4b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIBCL
CL$191,200.00
7D
0.7%
1Y
35.7%
Biogen
Market Cap: US$31.4b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIB
US$209.15
7D
1.0%
1Y
60.6%
Amgen
Market Cap: US$229.9b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$419.38
7D
0.5%
1Y
64.4%
Eli Lilly
Market Cap: CL$1.1t
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLYCL
CL$1,081,600.00
7D
-4.2%
1Y
61.2%